StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

PMCBNeutralStock Splitnews
Medium materiality4/10

PharmaCyte Biotech, Inc. Announces Reverse Stock Split

Nov 11, 2026, 9:43 AM EST1 sourcesAI-analyzed
Why it may matterVerify against the original reporting

A reverse split is a governance action that reduces outstanding share count and can affect per-share metrics and listing compliance; the economic impact on revenue or cash is indirect and depends on the split ratio and any related filings.

AI summary

What happened, with direct paths to the underlying reporting

PharmaCyte Biotech announced a reverse stock split.

  • PharmaCyte Biotech, Inc. announces a reverse stock split.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.